Barely a month goes by without a media report of the next breakthrough in cancer or other rare and life-threatening diseases.  Unfortunately, it can take precious time for patients to receive the benefit of the latest medical innovation. 

In June 2023, Bellberry gathered representatives of regulators, reimbursement agencies, pharmaceutical companies and, most importantly, patient groups from around the globe to Adelaide, Australia, to examine the issue of accelerated access to potentially beneficial medicines. 

The challenge for the group was to agree on the principles to be considered when establishing processes to provide faster access to life-saving treatments. 

Gathering these experts in one place to focus on this difficult issue for three-and-a-half days was an achievement in itself. 

In this episode of From Lab To Life we meet some of the experts who attended this International Scientific Congress and hear their thoughts on this complex issue.